Sales grew 4% organically to SEK 2,454 million, with both Medical and Engineered Solutions contributing. EBITA margin declined to 10.1% due to raw material cost pressures, but the financial position remains strong and expansion projects are on track.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.